Italo Beria

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Barbara Valsasina, Italo Beria, Cristina Alli et al. · Molecular Cancer Therapeutics · 2012 · 119 citations · Full text

Bipolar Spindle Formation, Antitumor Activity, Cell Death +17

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor

Italo Beria, R Bossi, Maria Gabriella Brasca et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 104 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +9

Identification of 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors

Italo Beria, Dario Ballinari, J. A. Bertrand et al. · Journal of Medicinal Chemistry · 2010 · 80 citations · Full text

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

Ulisse Cucchi, Laura Gianellini, Anna De Ponti et al. · PubMed · 2010 · 62 citations

Molecular Regulation, Cell Death, Pathology +21

Synthesis and Antitumor Activity of New Benzoheterocyclic Derivatives of Distamycin A

Pier Giovanni Baraldi, Romeo Romagnoli, Italo Beria et al. · Journal of Medicinal Chemistry · 2000 · 44 citations · Full text